You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

89Zr-DFO-MSTP2109A

Showing 101 - 124 of 124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in France, Netherlands, United States (RO5429083)

Completed
  • Neoplasms
  • Houston, Texas
  • +5 more
Nov 1, 2016

Chronic Iron Overload Trial in Cyprus, Egypt, Italy (Deferiprone, dose level 1, Deferiprone, dose level 2, Deferiprone, dose

Completed
Has Results
  • Chronic Iron Overload
  • Deferiprone, dose level 1
  • +2 more
  • Nicosia, Cyprus
  • +6 more
Nov 11, 2016

Sentinel Lymph Node Trial in Amsterdam (89Zr-nanocoll and Indocyanine Green)

Completed
  • Sentinel Lymph Node
  • 89Zr-nanocoll and Indocyanine Green
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Jul 29, 2016

VEGF Imaging in Renal Cell Carcinoma

Completed
  • Renal Cell Carcinoma
  • 89Zr-Bevacizumab PET-scan
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 1, 2015

Metastatic Breast Cancer Trial in Groningen (89Zr-trastuzumab injection)

Completed
  • Metastatic Breast Cancer
  • 89Zr-trastuzumab injection
  • Groningen, Netherlands
    University Medical Center
Nov 4, 2015

Subarachnoid Hemorrhage Trial in Boston (desferrioxamine (DFO), )

Terminated
  • Subarachnoid Hemorrhage
  • desferrioxamine (DFO)
  • placebo
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 17, 2015

Stage IV Cancer Trial in Maastricht (Cetuximab-Zr. 89)

Completed
  • Stage IV Cancer
  • Cetuximab-Zr. 89
  • Maastricht, Netherlands
    Maastro Clinic
Apr 9, 2015

Beta-Thalassemia Trial in New York (Deferitrin (GT56-252), desferoxamine (DFO))

Completed
  • Beta-Thalassemia
  • Deferitrin (GT56-252)
  • desferoxamine (DFO)
  • New York, New York
    The New York Presbyterian Hospital-Weill Medical College of Corn
Mar 4, 2015

Vascular Endothelial Growth Factor Imaging Before and During

Completed
  • Metastatic Renal Cell Carcinoma
  • 89Zr-bevacizumab PET scan
  • Groningen, Netherlands
    University Medical Centre Groningen
Jan 27, 2015

Ovarian Tumors, Ovarian Diseases, Adnexal Diseases Trial in Amsterdam, Groningen (89Zr-MMOT0530A)

Completed
  • Ovarian Neoplasms
  • +6 more
  • Amsterdam, Netherlands
  • +1 more
Oct 27, 2014

Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,

Completed
Has Results
  • Transfusional Iron Overload
  • Transfusional Hemosiderosis
  • Core Study: Deferasirox
  • +5 more
  • Toronto, Ontario, Canada
  • +20 more
Aug 13, 2014

Glioblastoma Trial in Groningen (Molecular imaging with 89Zr-RO5323441)

Withdrawn
  • Glioblastoma
  • Molecular imaging with 89Zr-RO5323441
  • Groningen, Netherlands
    University Medical Center Groningen
Mar 27, 2014

Beta-thalassemia Major Trial (DFX(Deferasirox), DFP(Deferiprone))

Completed
  • Beta-thalassemia Major
  • (no location specified)
Jul 22, 2014

Multiple Myeloma Trial in Groningen (89Zr-bevacizumab)

Unknown status
  • Multiple Myeloma
  • Groningen, Netherlands
    UMCG
May 17, 2013

89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition

Completed
  • Breast Cancer
  • Imaging with 89Zr-trastuzumab PET
  • Groningen, Netherlands
    University Medical Center Groningen
May 13, 2013

Visualizing Vascular Endothelial Growth Factor Producing Lesions

Completed
  • Von Hippel-Lindau Disease
  • +4 more
  • 89Zr bevacizumab PET scan
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 5, 2012

Primary Brain Tumors Trial in Groningen (89Zr-GC1008, GC1008)

Completed
  • Primary Brain Tumors
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 13, 2012

Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron

Completed
  • Breast Cancer
  • 89Zr-bevacizumab PET imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Sep 5, 2012

89Zr-bevacizumab PET Imaging in Neuroendocrine Tumors

Completed
  • Neuroendocrine Tumors
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 2, 2012

Beta-thalassemia Major, Sickle Cell Disease, Iron Hemosiderosis Trial in Cairo (DFP (ferriprox) and deferasirox (ICL 670), DFP,

Unknown status
  • Beta-thalassemia Major
  • +2 more
  • DFP (ferriprox) and deferasirox (ICL 670)
  • DFP, DFO
  • Cairo, Egypt
    Pediatric Hematology clinic, Ain Shams University
Feb 3, 2012

Sickle Cell Disease Trial in Worldwide (ICL670)

Completed
Has Results
  • Sickle Cell Disease
  • Mobile, Alabama
  • +38 more
May 3, 2011

Thalassemia Trial in New York (Deferoxamine, Deferasirox)

Unknown status
  • Thalassemia
  • New York, New York
    Weill Cornell Medical Center
Nov 4, 2010

Iron Overload, Cardiomyopathy Trial in Cagliari (Deferoxamine and Deferiprone, Deferoxamine)

Completed
  • Iron Overload
  • Cardiomyopathy
  • Cagliari, Sardinia, Italy
    Adult Talassemic Center, Ospedale Microcitemico
Dec 1, 2008

Beta-Thalassemia, Thalassemia Major Trial in Palermo (Deferiprone (DFP) and Deferoxamine (DFO), Deferiprone (DFP))

Completed
  • Beta-Thalassemia
  • Thalassemia Major
  • Deferiprone (DFP) and Deferoxamine (DFO)
  • Deferiprone (DFP)
  • Palermo, Italy
    Ao V. Cervello
Aug 12, 2008